Inclusion of genomic profiling and risk factors recommended for treatment planning
Universal testing could reduce expected costs compared to EGFR single gene testing
Molecular tumor profiling is available to patients
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement